Citation: | LI Yan-mei, LIU Chang, CONG Tian-xin, et al. Clinical and Neuroimaging Analysis of 24 Cases of Sturge-Weber Syndrome[J]. Journal of Sichuan University (Medical Sciences), 2020, 51(4): 562-566. DOI: 10.12182/20200760505 |
[1] |
SUDAARSANAM A, ARDERN-HOLMES S L. Sturge-Weber syndrome: from the past to the present. Eur J Paediatr Neurol,2014,18(3): 257–266. DOI: 10.1016/j.ejpn.2013.10.003
|
[2] |
PIRAM M, LORETTE G, SIRINELLI D, et al. Sturge-Weber syndrome in patients with facial port-wine stain. Pediatr Dermatol,2012,29(1): 32–37. DOI: 10.1111/j.1525-1470.2011.01485.x
|
[3] |
SHIRLEY M D, TANG H, GALLIONE C J, et al. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med,2013,368(21): 1971–1979. DOI: 10.1056/NEJMoa1213507
|
[4] |
POLUBOTHU S, A-OLABI L, CARMEN DEL BOENTE M,et al. GNA11 mutation as a cause of Sturge-Weber syndrome: expansion of the phenotypic spectrum of G-protein related mosaicism and the associated clinical diagnoses. J Invest Dermatol,2020,140(5): 1110–1113. DOI: 10.1016/j.jid.2019.10.019.Epub2019Dec12.
|
[5] |
DUTKIEWICZ A S, EZZEDINE K, MAZEREEUW-HAUTIER J, et al. A prospective study of risk for Sturge-Weber syndrome in children with upper facial port-wine stain. J Am Acad Dermatol,2015,72(3): 473–480. DOI: 10.1016/j.jaad.2014.11.009
|
[6] |
PALLER A S. The Sturge-Weber syndrome. Pediatr Dermatol,1987,4(4): 300–304. DOI: 10.1111/j.1525-1470.1987.tb00797.x
|
[7] |
WAELCHLI R, AYLETT S E, ROBINSON K, et al. New vascular classification of port-wine stains: improving prediction of Sturge-Weber risk. Br J Dermatol,2014,171(4): 861–867. DOI: 10.1111/bjd.13203
|
[8] |
中华医学会整形外科分会血管瘤和脉管畸形学组. 血管瘤和脉管畸形的诊断及治疗指南(2019版). 组织工程与重建外科杂志,2019,15(5): 277–317. DOI: 10.3969/j.issn.1673-0364.2019.05.001
|
[9] |
MELANCON J M, DOHIL M A, EICHENFIELD L F. Facial port-wine stain: when to worry? Pediatr Dermatol,2012,29(1): 131–133. DOI: 10.1111/j.1525-1470.2011.01720.x
|
[10] |
MOHAMMADIPANAH F, SALIMI F. Potential biological targets for bioassay development in drug discovery of Sturge-Weber syndrome. Chem Biol Drug Des,2018,91(2): 359–369. DOI: 10.1111/cbdd.13112
|
[11] |
KOENRAADS Y, VAN EGMOND-EBBELING M B, DE BOER J H, et al. Visual outcome in Sturge-Weber syndrome: a systematic review and Dutch multicentre cohort. Acta Ophthalmol,2016,94(7): 638–645. DOI: 10.1111/aos.13074
|
[12] |
CHO S, MAHARATHI B, BALL K L, et al. Sturge-Weber syndrome patient registry: delayed diagnosis and poor seizure control. J Pediatr, 2019, 215: 158-163.e6[2020-01-05].https://www.jpeds.com/article/S0022-3476(19)31083-2/fulltext. doi: 10.1016/j.jpeds.2019.08.025.
|
[13] |
SUJANSKY E, CONRADI S. Sturge-Weber syndrome: age of onset of seizures and glaucoma and the prognosis for affected children. J Child Neurol,1995,10(1): 49–58. DOI: 10.1177/088307389501000113
|
[14] |
ZALLMANN M, MACKAY M T, LEVENTER R J, et al. Retrospective review of screening for Sturge-Weber syndrome with brain magnetic resonance imaging and electroencephalography in infants with high-risk port-wine stains. Pediatr Dermatol,2018,35(5): 575–581. DOI: 10.1111/pde.13598
|
[15] |
HU J, YU Y, JUHASZ C, et al. MR susceptibility weighted imaging (SWI) complements conventional contrast enhanced T1 weighted MRI in characterizing brain abnormalities of Sturge-Weber syndrome. J Magn Reson Imaging,2008,28(2): 300–307. DOI: 10.1002/jmri.21435
|
[16] |
PILLI V K, BEHEN M E, HU J, et al. Clinical and metabolic correlates of cerebral calcifications in Sturge-Weber syndrome. Dev Med Child Neurol,2017,59(9): 952–958. DOI: 10.1111/dmcn.13433
|
[17] |
ZALLMANN M, LEVENTER R J, MACKAY M T, et al. Screening for Sturge-Weber syndrome: a state-of-the-art review. Pediatr Dermatol,2018,35(1): 30–42. DOI: 10.1111/pde.13304
|
1. |
刘璐,谢乐,伍大华,姚婷. 神经皮肤综合征研究进展. 中风与神经疾病杂志. 2024(11): 1051-1056 .
![]() | |
2. |
姚晓英. 脑面血管瘤病1例叙事护理. 中国乡村医药. 2023(01): 64-65+74 .
![]() | |
3. |
王思慧,王晓晨,赵雪宁,孙胜军. 脑膜血管瘤病的影像学表现. 临床放射学杂志. 2022(12): 2185-2188 .
![]() |